A new intraoperative imaging platform called ULTRA combines rapid tissue clearing, stimulated Raman scattering microscopy, and AI-based virtual staining to perform deep 3D histological imaging. This enables the visualization of key histological features across different glioma subtypes and facilitates glioma margin analysis.
SourceFudan University Institute of Science and Technology·JournalCell·TypeComputational simulation/modeling·DateAug 14, 2026
Researchers developed a new therapeutic that targets cancer cells without harming healthy ones, significantly shrinking tumors in mice. The treatment, Pro-LYTAC, is activated within tumor cells and directed to lysosomes for degradation, restoring immune recognition of cancer cells.
SourceAmerican Chemical Society·JournalJournal of Medicinal Chemistry·DateAug 13, 2026
The updated guideline provides evidence-based recommendations on radiation therapy for adult patients with pancreatic cancer, clarifying its role in various settings. It recommends radiation therapy for patients with resectable, locally advanced, and metastatic disease, as well as those with recurrent or palliative needs.
SourceAmerican Society for Radiation Oncology·JournalPractical Radiation Oncology·DateAug 13, 2026
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
A randomized clinical trial of 698 patients with localized intermediate-risk prostate cancer found that stereotactic body radiotherapy was not superior to moderately hypofractionated IMRT for disease-free survival at 3 years. However, SBRT showed better bowel-related quality of life compared to IMRT.
A study published in JAMA Otolaryngology–Head & Neck Surgery found that preoperative chemo-immunotherapy was more effective than immunotherapy alone in reducing tumor size in patients with head and neck cancer. The study analyzed data from 86 adults with head and neck cancer treated between July 2024 and March 2026, and showed that pat...
SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJAMA Otolaryngology–Head & Neck Surgery·DateAug 13, 2026
Recent research explores the use of nanomaterial-based drug delivery to increase treatment efficacy for glioblastoma, a type of brain tumor with poor prognosis. Stimuli-responsive and biomimetic nanomedicines are designed to overcome the blood–brain barrier and deliver drugs selectively within tumors.
SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeSystematic review·DateAug 12, 2026
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
Researchers reviewed grant data from 2015-2022, supporting investment in a strong evidence base for obesity and cancer research. Key areas of focus include obesity's impact on cancer treatment and survivorship, as well as disparities in cancer outcomes.
SourceJAMA Network·JournalJAMA Network Open·DateAug 12, 2026
Researchers identified NUDT5 as a key player in the molecular mechanisms determining whether cells succumb to or survive 6-TG. Targeted protein degradation revealed that degrading NUDT5 protects cells from the drug's toxic effects.
SourceCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences·JournalNature Communications·DateAug 12, 2026
Scientists at Cancer Research UK Scotland Institute and University of Glasgow identify a new pathway for delivering antisense oligonucleotides (ASOs) into cells, enhancing the effectiveness of ASO-based therapy for pancreatic cancer and other diseases. The researchers found that ASOs enter cells via endocytosis and bind to specific rec...
SourceRockefeller University Press·JournalJournal of Cell Biology·TypeExperimental study·DateAug 11, 2026
Researchers identified two immune cell populations present in both initial and recurrent arthritis flares, suggesting an immune-memory disease. These cells may serve as biomarkers for high-risk patients or to guide targeted therapies to reduce side effects.
SourceUniversity of Texas M. D. Anderson Cancer Center·JournalCancer Immunology Research·DateAug 11, 2026
Scientists at Gladstone Institutes and UCSF discovered a pair of genetic edits that make CAR-T cells more effective against solid tumors. The new CRISPR screening platform enables the study of gene edits on CAR-T cells inside living mice, uncovering therapeutic targets previously missed in conventional cell culture systems.
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
A recent real-world study indicates that reaching a PSA level below 0.2 ng/mL is associated with improved patient survival, and this cutoff may be the best metric for determining treatment success, according to investigators analyzing Veterans Health Administration data.
Researchers developed a simple, fast, and low-cost blood test that identifies the tumor's biological fingerprint with over 90% accuracy. The test distinguishes between lung cancer patients and healthy individuals without DNA sequencing.
SourceTel-Aviv University·Journalnpj Precision Oncology·DateAug 10, 2026
The partnership aims to increase enrollment in clinical trials, making research opportunities more accessible to patients. UCCCC and Lilly will work together to open studies faster and connect more patients with research opportunities.
Dr. Amoako's evidence-driven services improve early diagnosis, expand access to treatment, and advance locally led research in Ghana. Her work aims to strengthen childhood cancer care across the country.
SourceInstitute for Health Metrics and Evaluation·DateAug 7, 2026
A large study reveals that dexrazoxane significantly reduces heart damage caused by chemotherapy in pediatric cancer patients years after treatment. The findings could change how doctors follow survivors for decades and provide families with reassurance about long-term effects.
SourceUniversity of Florida·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateAug 7, 2026
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
A Brazilian engineer's family is diagnosed with hereditary medullary carcinoma after genetic testing reveals an inherited mutation in the RET gene. The condition was initially reactive but shifted to preventive and precision strategies, allowing for earlier interventions and improved outcomes.
SourceFundação de Amparo à Pesquisa do Estado de São Paulo·DateAug 6, 2026
A phase 3 clinical trial led by Weill Cornell Medicine shows that adding a targeted radionuclide therapy drug to backbone therapy reduces disease progression in patients with PSMA-positive metastatic prostate cancer. The treatment may delay symptom progression and improve patient outcomes.
SourceWeill Cornell Medicine·JournalThe Lancet·DateAug 6, 2026
Researchers have developed an experimental drug that tricks cancer cells into consuming more sugar than usual, then blocks their backup fuel source – fat. This approach puts cancer cells under so much stress that many die, demonstrating effectiveness in treating aggressive melanoma in mice.
SourceUniversity of Texas at Austin·JournalNature Chemical Biology·TypeExperimental study·DateAug 5, 2026
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers found that IVMT-Rx-4 selectively blocks the function of the MDA-9/Syntenin protein, limiting tumor growth and eliminating therapy resistance in preclinical cancer models. The study suggests a new targeted treatment option for head and neck squamous cell carcinoma.
SourceVirginia Commonwealth University·JournalCancer Letters·DateAug 5, 2026
Researchers have identified a promising strategy to improve the effectiveness of targeted therapies in advanced prostate cancer. By combining ADCs with a drug that blocks BCL-XL, they triggered greater cancer cell death and slowed tumor growth. The approach could offer a new strategy for improving antibody-drug conjugates against metas...
SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of Clinical Investigation·DateAug 3, 2026
A KAIST research team has developed an RNA-based therapeutic strategy that blocks a brain signal to prevent muscle loss and extend survival in cancer patients. The treatment showed significant improvements in both muscle loss and metabolic dysfunction, with a notable increase in survival rates among treated mice.
SourceThe Korea Advanced Institute of Science and Technology (KAIST)·JournalCell Reports Medicine·DateAug 1, 2026
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
A study found that reshaping the gut microbiome with antibiotics can significantly reduce liver clearance and double chemotherapy delivery to tumors. This approach has potential as a strategy to enhance nanoparticle-based cancer drugs.
SourceUniversity of Texas M. D. Anderson Cancer Center·JournalNature Materials·DateJul 31, 2026
A multidisciplinary team of Penn researchers has developed a platform that delivers a combination of cancer-fighting therapies to treat oral squamous cell carcinoma. The findings show that the platform significantly reduces tumor burden and extends survival in aggressive, p53-therapy-resistant cancer models.
SourceUniversity of Pennsylvania·JournalAdvanced Materials·TypeExperimental study·DateJul 30, 2026
A recent analysis found that while genomic testing increased among Medicare recipients, many patients still lack next-generation sequencing tests. This limits their access to precision medicine and targeted therapies. The study highlights the need for further research on how increased testing impacts patient outcomes.
SourceGeorgetown University Medical Center·JournalJAMA Network Open·TypeData/statistical analysis·DateJul 29, 2026
Researchers found that immature NK cells in donated cord blood can undermine CAR NK cell therapy by creating false targets for therapeutic cells to attack. Removing these cells before manufacturing improves therapy outcomes, persistence and antitumor activity in preclinical models of lymphoma and ovarian cancer.
SourceUniversity of Texas M. D. Anderson Cancer Center·JournalCancer Cell·DateJul 29, 2026
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Researchers discovered a signaling pathway activated by acidic tumor environments that drives resistance to PARP inhibitors. Blocking the pathway resensitizes tumors, suggesting a potential new therapeutic strategy for overcoming acquired resistance.
SourceUniversity of Texas M. D. Anderson Cancer Center·JournalCancer Research·DateJul 29, 2026
Circulating circRNAs show high cell-type and tissue specificity, making them ideal for non-invasive cancer management. They can be detected in multiple body fluids and reflect treatment response, positioning them as functional drivers of therapy resistance.
SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateJul 28, 2026
The University of Tennessee has appointed Carolyn J. Anderson as a UT-Oak Ridge National Laboratory Governor's Chair for Nuclear Medicine. She will focus on researching radioisotopes produced at ORNL for targeted alpha-emitting radiotherapy, which can precisely kill cancer cells with minimal side effects.
Dr. Yi Li receives CPRIT funding to develop treatments for solitary fibrous tumor, a rare cancer driven by gene fusions. Researchers are working on novel therapies, including immunotherapy and antisense oligonucleotides, to reduce cancer-causing signal activity.
Apple iPad Pro 11-inch (M4)
Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.
A new study published in eBioMedicine shows that combining irinotecan with standard chemoradiotherapy improves survival against advanced rectal cancer, particularly in those with high concentrations of cancerous cells. The AI-powered analysis revealed a 43% reduction in cancer recurrence and a 50% reduction in death risk.
SourceUniversity College London·JournalEBioMedicine·TypeObservational study·DateJul 27, 2026
Researchers discover how tumors hijack the thymus to evade immune surveillance by transporting tumor antigens there. Disrupting a specific chemokine receptor may enhance anti-tumor immunity and improve cancer treatment outcomes.
SourceChiba University·JournalScience Advances·TypeExperimental study·DateJul 23, 2026
Researchers at Nagoya University discovered that complement C3 protein acts inside tumors to prevent immunosuppressive cells, improving cancer immunotherapy effectiveness. Higher levels of C3 in tumor tissue were associated with better treatment outcomes and survival rates in patients.
SourceNagoya University·JournalNature Communications·TypeExperimental study·DateJul 23, 2026
A comprehensive, sustained approach to treating tobacco dependence in patients undergoing cancer treatment has been shown to double quit rates compared to referral to a Quitline alone. The study found that 81% of participants who received virtual sustained treatment attended counseling sessions and had higher medication use rates.
SourceECOG-ACRIN Cancer Research Group·JournalJournal of Clinical Oncology·DateJul 23, 2026
Researchers discovered 171 distinct mutations causing MET exon 14 skipping in lung cancer patients. RNA-based testing confirmed these alterations, highlighting the importance of complementary diagnostic approaches.
SourceElsevier·JournalJournal of Molecular Diagnostics·TypeData/statistical analysis·DateJul 23, 2026
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.
Researchers analyzed over 600 tumors from 544 patients and found distinct genomic signatures of DNA changes linked to different chemotherapies. These patterns appeared as early as 91 days after treatment began, allowing clinicians to track treatment-resistant tumours and potentially reduce toxic effects. The study could lead to a more ...
SourceThe Hospital for Sick Children·JournalNature·DateJul 23, 2026
Researchers have found that a combination of enfortumab vedotin and pembrolizumab helps patients with muscle-invasive bladder cancer live longer while reducing the risk of recurrence after surgery. Nearly 80% of patients who received this treatment remained free of disease progression, recurrence, or death two years after treatment began.
SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNew England Journal of Medicine·TypeCase study·DateJul 23, 2026
Researchers used advanced 3D genome mapping technology to study prostate cancer cells and discovered a new feature of gene control networks that could help fight cancer. The study found that enhancers work cooperatively in 3D networks, with some acting as central hubs that control many genes.
SourceKeck School of Medicine of USC·JournalGenome Biology·TypeExperimental study·DateJul 22, 2026
A research team has overcome two major hurdles for photo thermal therapy, a less invasive treatment option than surgery and radiation. They created a new biodegradable protein called IDP1 that helps nanoparticles avoid immune detection, and developed an ultra-thin endoscope to deliver laser light directly into tumors.
SourceTohoku University·JournalSmall Science·DateJul 22, 2026
A UMass Amherst-led team is developing a new approach to prevent bladder cancer recurrence by exfoliating the bladder lining. The technology uses irreversible electroporation to target premalignant cells, offering a potential alternative to surgical removal or aggressive treatments.
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
Researchers found that a new treatment regimen can slow cancer progression in patients with functional high-risk (FHR) multiple myeloma. The study defines FHR multiple myeloma as progressing within 36 months of starting treatment, indicating a survival prognosis of less than 2 years after progression.
The grant supports the development of therapies with fewer side effects for triple-negative breast cancer, a highly aggressive and difficult-to-treat form of breast cancer. The researchers aim to target UBR5 protein, which is overproduced in aggressive breast cancers and several other malignancies.
A study published in Cancer Research identified an immune pathway that promotes the progression of oral precancerous lesions into head and neck squamous cell carcinoma. The researchers found that targeting a key inflammation signal known as interleukin-1 alpha (IL-1α) could help restore immune surveillance and prevent high-risk lesions...
SourceUniversity of Texas M. D. Anderson Cancer Center·JournalCancer Research·DateJul 16, 2026
Researchers at Johns Hopkins Medicine have found a potential therapeutic target that can improve the potency of decitabine, a chemotherapy commonly used to treat bone marrow disorders and acute myeloid leukemia. By blocking DCTPP1's function with newly identified inhibitors, cancer cells become more susceptible to decitabine's ability ...
SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateJul 15, 2026
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
The ECOG-ACRIN ENDURANCE trial found that indefinite lenalidomide maintenance had no survival benefit and more toxicity compared to stopping treatment after 2 years in patients not undergoing a stem cell transplant. The study suggests that fixed duration treatment can significantly reduce healthcare costs.
SourceECOG-ACRIN Cancer Research Group·JournalNew England Journal of Medicine·DateJul 15, 2026
A new study found that a virtual smoking cessation treatment program nearly doubled quit rates for cancer patients who currently smoke. The program, delivered at community oncology care settings, was both cost-effective and satisfying for patients. Participants who completed more sessions had a higher likelihood of quitting.
SourceMass General Brigham·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateJul 14, 2026
Researchers developed nanoparticles that retain their protective coating in normal tissue but shed it upon reaching tumor tissue, releasing anticancer drugs. This technology reduces systemic side effects and enhances treatment efficacy.
SourcePohang University of Science & Technology (POSTECH)·JournalBiomaterials·DateJul 14, 2026
A novel therapy targeting the bone marrow microenvironment is shown to accelerate recovery and promote hematopoietic regeneration after injury. Pharmacological activation of YAP/TAZ improves BM niche recovery, enhancing engraftment and white blood cell recovery following HSCT.
SourceThe Institute of Medical Science, The University of Tokyo·JournalBlood·TypeExperimental study·DateJul 10, 2026
A nationwide analysis found that many radiation oncology clinics have closed, particularly in rural communities, reducing access to lifesaving cancer treatment. The study suggests that understanding which communities are most vulnerable can help policymakers develop strategies to preserve access.
SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalInternational Journal of Radiation Oncology*Biology*Physics·TypeData/statistical analysis·DateJul 10, 2026
Davis Instruments Vantage Pro2 Weather Station
Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.
A new study found that over 50 million Americans live in counties without a radiation oncology clinic, highlighting vulnerabilities in the nation's cancer care infrastructure. Radiation oncology practices have closed disproportionately in rural areas and freestanding settings, raising concerns about patients' access to cancer care.
SourceAmerican Society for Radiation Oncology·JournalInternational Journal of Radiation Oncology*Biology*Physics·DateJul 9, 2026
A new strategy makes stem cell transplants safer by replacing chemotherapy-based treatment with targeted antibodies that recognize specific markers on blood-forming stem cells. This approach allows for less toxic treatment and could enable chemotherapy-free or chemotherapy-sparing transplantation approaches.
SourceBoston Children's Hospital·JournalNature·DateJul 8, 2026
Researchers at Umeå University have developed a new antibody that successfully halted tumor growth and metastasis in aggressive prostate cancer. The treatment works through a novel mechanism of action, potentially reducing side effects.
SourceUmea University·JournalSignal Transduction and Targeted Therapy·TypeExperimental study·DateJul 7, 2026
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
Researchers identified why some patients with rare blastic plasmacytoid dendritic cell neoplasm (BPDCN) leukemia don't respond to tagraxofusp. Severe TET2 gene mutations and low TXNRD1 enzyme levels contribute to resistance, suggesting these biomarkers could predict treatment outcomes.
SourceUniversity of Texas M. D. Anderson Cancer Center·JournalLeukemia·DateJul 7, 2026
Physicists at UTEP have discovered a new type of manganese ferrite nanoparticle that can deliver targeted heat treatment to tumors, potentially improving cancer therapies. The nanoparticles were found to produce a stronger heating response than other materials, making them a promising building block for future treatments.
SourceUniversity of Texas at El Paso·JournalScientific Reports·DateJul 7, 2026
Researchers have developed a gene-editing tool that unlocks the secrets of fungi, a kingdom rich in antibacterial compounds. The tool, called fPE7max, enables precise control over DNA sequences and has identified three novel molecules with anti-cancer properties.
SourceUniversity of Pennsylvania·JournalNature Biotechnology·TypeExperimental study·DateJul 2, 2026
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
A Phase I/II study showed high tumor shrinkage and substantial reductions in cancer DNA detected in the bloodstream. The treatment combination of zoldonrasib with chemotherapy improved patient outcomes, suggesting a potential breakthrough in personalized treatment for pancreatic cancer.
SourceEuropean Society for Medical Oncology·DateJul 2, 2026
Researchers at the University of Warwick and Monash University have uncovered a molecular basis for combinatorial biosynthesis, a strategy to create multiple versions of powerful cancer therapies. By understanding how bacterial enzymes interact, they can design new therapies with improved potency and selectivity.
SourceUniversity of Warwick·JournalNature Communications·TypeExperimental study·DateJul 1, 2026
Researchers have uncovered a potential strategy to eliminate cancer cells that survive KRAS inhibition, preventing relapse. By targeting the metabolic pathways that support the survival of drug-tolerant persister cells, treatment regimens could be designed to shrink tumors and prevent cancer recurrence.
SourceChiba University·JournalCommunications Biology·TypeExperimental study·DateJun 25, 2026
Creality K1 Max 3D Printer
Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.
Researchers at Texas A&M University develop a laser technique called TRIP to directly measure quantum forces shaping proteins, enabling accurate prediction of how pharmaceutical drugs interact with them. This breakthrough could lead to the design of medicines tailored to specific diseases, revolutionizing precision medicine.
SourceTexas A&M University·JournalScience Advances·DateJun 25, 2026
Researchers will develop genetic boosters and "two-factor authentication" for CAR T cell therapy, targeting HER2-positive lung, breast, and colon tumors. The project aims to improve the efficacy of CAR T cells against solid tumors while reducing collateral damage.
SourceCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences·DateJun 23, 2026